Therapeutic resistance in breast cancer: Impact of growth factor signalling pathways and implications for future treatment. Proceedings of the 1st Tenovus/AstraZeneca workshop, 3-4 February 2005, Cardiff, United Kingdom.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm; D006131:Growth Inhibitors / Q000627:therapeutic use*; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D015398:Signal Transduction / Q000187:drug effects
D000970:Antineoplastic Agents; D006131:Growth Inhibitors; D006133:Growth Substances